Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse

Infect Immun. 2004 Apr;72(4):2438-41. doi: 10.1128/IAI.72.4.2438-2441.2004.

Abstract

Rectal instillation of trinitrobenzene sulfonic acid (TNBS) induces acute colitis in the mouse. We tested the efficacy of Yersinia pseudotuberculosis anti-inflammatory components in preventing TNBS-triggered colitis. Animals were orally inoculated with virulence-attenuated Yersinia cells (a phoP mutant) prior to TNBS administration. Under these experimental conditions, colonic lesions and tumor necrosis factor alpha mRNA levels were significantly reduced.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colitis / chemically induced
  • Colitis / immunology*
  • Colitis / physiopathology
  • Disease Models, Animal
  • Female
  • Humans
  • Inflammation
  • Inflammatory Bowel Diseases / immunology
  • Mice
  • Mice, Inbred C57BL
  • Trinitrobenzenesulfonic Acid / pharmacology*
  • Tumor Necrosis Factor-alpha / immunology*
  • Tumor Necrosis Factor-alpha / metabolism
  • Yersinia pseudotuberculosis / immunology*
  • Yersinia pseudotuberculosis / pathogenicity
  • Yersinia pseudotuberculosis Infections / immunology*

Substances

  • Tumor Necrosis Factor-alpha
  • Trinitrobenzenesulfonic Acid